IMP
Process View
positive regulation of cyclin dependent protein serine threonine kinase activity involved in g1 s transition of mitotic cell cycle
Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cyclin dependent protein serine threonine kinase activity involved in g1 s transition of mitotic cell cycle"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.998 | ||
| EGFR | epidermal growth factor receptor | 0.998 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.914 | Human | |
| FGF1 | fibroblast growth factor 1 (acidic) | 0.857 | Human | |
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.743 | ||
| ABI2 | abl-interactor 2 | 0.739 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.552 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.468 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.369 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.298 | ||
| FGF10 | fibroblast growth factor 10 | 0.249 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.211 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.163 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.131 | ||
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.095 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.091 | ||
| DNM1 | dynamin 1 | 0.060 | ||
| SH3D19 | SH3 domain containing 19 | 0.046 | ||
| MAPT | microtubule-associated protein tau | 0.045 | ||
| APP | amyloid beta (A4) precursor protein | 0.044 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.042 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.039 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.038 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.035 | ||
| SNX33 | sorting nexin 33 | 0.034 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.027 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.026 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.024 | ||
| SNX9 | sorting nexin 9 | 0.023 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.022 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.021 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.021 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.021 | ||
| CD2 | CD2 molecule | 0.019 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.017 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.017 | ||
| SYK | spleen tyrosine kinase | 0.017 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.016 | ||
| INSR | insulin receptor | 0.015 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.015 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.015 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.015 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.014 | Human | |
| ADAM15 | ADAM metallopeptidase domain 15 | 0.014 | Human | |
| SH2D1A | SH2 domain containing 1A | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.011 | ||
| BAD | BCL2-associated agonist of cell death | 0.011 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.011 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
| FGF7 | fibroblast growth factor 7 | 0.011 | Human |